Clinical trial
The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of…
NCT00001082 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00001082 |
|---|---|
| Title | The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients |
| Official title | A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Adefovir Dipivoxil (Bis-POM PMEA) in Prolonging Survival of HIV-Infected Individuals With a CD4+ Cell Count of <= 100/mm3 or With a CD4+ Cell Count Both > 100 and <= 200/mm3 and a Nadir CD4+ Cell Count of… |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cytomegalovirus Infections, HIV Infections |
| Intervention type | Drug |
| Interventions | Levocarnitine, Adefovir dipivoxil, Adefovir dipivoxil placebo |
| Enrollment | 505 |
| Start date | Dec 1, 1996 |
| Primary completion | Jan 1, 1999 |
| Completion | Aug 1, 1999 |
| First posted | Aug 31, 2001 |
| Last update posted | Oct 1, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: